Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial (Q46616032)

From Wikidata

Jump to navigation Jump to search

scientific article published on 21 July 2005

Language	Label	Description	Also known as
English	Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial	scientific article published on 21 July 2005

Statements

scholarly article

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16040619

Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial (English)

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16040619

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic heart failure

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16040619

4

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16040619

Christian Torp-Pedersen

2

object named as

Christian Torp-Pedersen

1 reference

Europe PubMed Central

23 December 2017

6

object named as

Michel Komajda

1 reference

Europe PubMed Central

23 December 2017

3

object named as

Karl Swedberg

1 reference

Europe PubMed Central

23 December 2017

Andrea Di Lenarda

5

object named as

Andrea Di Lenarda

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16040619

Beatrix Lutiger

8

object named as

Beatrix Lutiger

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16040619

Willem J. Remme

7

object named as

Willem J Remme

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16040619

9

object named as

Armin Scherhag

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16040619

10

object named as

Mary Ann Lukas

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16040619

author name string

Andrew Charlesworth

11

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16040619

Philip A Poole-Wilson

12

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16040619

publication date

21 July 2005

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16040619

European Heart Journal

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16040619

26

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16040619

21

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16040619

2259-2268

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16040619

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Effect of carvedilol on survival in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

beta-adrenergic receptor blockade in chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Mode of death in heart failure: findings from the ATLAS trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure: COMET.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Guidelines for the diagnosis and treatment of chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Predicting response to carvedilol for the treatment of heart failure: a multivariate retrospective analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Relation between heart rate, heart rhythm, and reverse left ventricular remodelling in response to carvedilol in patients with chronic heart failure: a single centre, observational study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Predictors of systolic and diastolic improvement in patients with dilated cardiomyopathy treated with metoprolol

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Beta-blocker efficacy according to heart rate and rhythm in patients with heart failure. Commentary on the Cardiac Insufficiency Bisoprolol Study II analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Do beta-blockers prolong survival in heart failure only by inhibiting the beta1-receptor? A perspective on the results of the COMET trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Beta blockers in heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Selective versus nonselective beta-blockade for heart failure therapy: are there lessons to be learned from the COMET trial?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Interaction between cardiac sympathetic drive and heart rate in heart failure: modulation by adrenergic receptor genotype

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Bucindolol, a nonselective beta 1- and beta 2-adrenergic receptor antagonist, decreases beta-adrenergic receptor density in cultured embryonic chick cardiac myocyte membranes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Carvedilol but not metoprolol reduces beta-adrenergic responsiveness after complete elimination from plasma in vivo

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

A comment on COMET: how to interpret a positive trial?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Specific beta(2)AR blocker ICI 118,551 actively decreases contraction through a G(i)-coupled form of the beta(2)AR in myocytes from failing human heart.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Bisoprolol dose-response relationship in patients with congestive heart failure: a subgroup analysis in the cardiac insufficiency bisoprolol study(CIBIS II).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI386

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHI386

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16040619

release_b6gupks2i5faparbhnfpid242q

1 reference

https://api.fatcat.wiki/v0/release/b6gupks2i5faparbhnfpid242q

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16040619

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46616032&oldid=2122294704"